You betcha. Could have some wild swings in it. Great for a day trade for the next few weeks, but I'm betting this one might run a little more. Used to trade in the 2.00+ range before some bad data hit late 2009. But the new data coming out is blockbuster in light of Dendreon's Provenge approval.
Here's some of the buzz pushing this stock right now. It is only a blog, but the data is available and will be presented at the end of the month. The company is hosting an annual shareholders meeting webcast tomorrow at 5 PM EST. Lots of buzz making its way around this one. I don't pretend to understand the nuances of biotechs, but the data dumbed down for me looks impressive. People are now looking for the next Dendreon, and AGEN has a similar type of cancer vaccine approach for brain cancer (glioma) that made Dendreon a 5 billion market cap company before approval of their first drug.